Home  /  Resource Library  /  Long-term efficacy and safety of chemotherapy-free first-line iodine-131-rituximab radioimmunotherapy of follicular lymphoma

Long-term efficacy and safety of chemotherapy-free first-line iodine-131-rituximab radioimmunotherapy of follicular lymphoma

Results of a study investigating iodine-131-rituximab for treatment of follicular lymphoma.